These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 15694188)
1. Conventional allograft and autograft in low grade lymphoma. Avivi I; Goldstone AH Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188 [TBL] [Abstract][Full Text] [Related]
2. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A; J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703 [TBL] [Abstract][Full Text] [Related]
3. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH; Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607 [TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350 [TBL] [Abstract][Full Text] [Related]
5. [Stem cell transplantation in patients with low-grade non-Hodgkin lymphoma]. Mandigers CM; Schattenberg AV; Raemaekers JM Ned Tijdschr Geneeskd; 2000 Oct; 144(43):2045-8. PubMed ID: 11072506 [TBL] [Abstract][Full Text] [Related]
6. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Nademanee A; Forman SJ Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658 [TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation for non-Hodgkin's lymphoma. Lin TS; Copelan EA Curr Hematol Rep; 2003 Jul; 2(4):310-5. PubMed ID: 12901328 [TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma. Pettengell R Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153 [TBL] [Abstract][Full Text] [Related]
10. Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma. Morris EC; Mackinnon S Best Pract Res Clin Haematol; 2005 Mar; 18(1):129-42. PubMed ID: 15694189 [TBL] [Abstract][Full Text] [Related]
11. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Naparstek E Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR). Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362 [TBL] [Abstract][Full Text] [Related]
14. Autologous and allogeneic stem cell transplantation in follicular lymphoma. Van Besien K Transfus Apher Sci; 2005 Feb; 32(1):45-53. PubMed ID: 15737873 [TBL] [Abstract][Full Text] [Related]
15. In vivo purging and relapse prevention following ASCT. Gisselbrecht C Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S5-9. PubMed ID: 11840154 [TBL] [Abstract][Full Text] [Related]
16. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208 [TBL] [Abstract][Full Text] [Related]
17. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation. Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639 [TBL] [Abstract][Full Text] [Related]
18. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Wildes TM; Augustin KM; Sempek D; Zhang QJ; Vij R; Dipersio JF; Devine SM Biol Blood Marrow Transplant; 2008 Jul; 14(7):840-6. PubMed ID: 18541205 [TBL] [Abstract][Full Text] [Related]
19. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Feyler S; Prince HM; Pearce R; Towlson K; Nivison-Smith I; Schey S; Gibson J; Patton N; Bradstock K; Marks DI; Cook G Bone Marrow Transplant; 2007 Sep; 40(5):443-50. PubMed ID: 17589529 [TBL] [Abstract][Full Text] [Related]
20. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma. Van Besien K Blood Rev; 2006 Sep; 20(5):235-44. PubMed ID: 16513231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]